# A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes

> **NCT00494663** · PHASE2 · TERMINATED · sponsor: **DiObex** · enrollment: 200 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** DIO-902
- **DRUG:** DIO-902
- **DRUG:** DIO-902
- **DRUG:** DIO-902 placebo
- **DRUG:** DIO-902
- **DRUG:** DIO-902
- **DRUG:** DIO-902
- **DRUG:** DIO-902 placebo

## Key facts

- **NCT ID:** NCT00494663
- **Lead sponsor:** DiObex
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2008-03
- **Final completion:** 2008-12
- **Target enrollment:** 200 (ESTIMATED)
- **Why stopped:** Program Terminated
- **Last updated:** 2008-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00494663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00494663, "A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00494663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*